Global Intravitreal Injectable Competitive Landscape Professional Research Report 2025
Description
Global Intravitreal Injectable Competitive Landscape Professional Research Report 2025
Research Summary
An intravitreal injectable is a medication administered directly into the vitreous cavity of the eye, which is the gel-like substance that fills the space between the lens and the retina. This injection is typically performed to deliver therapeutic agents for the treatment of various eye conditions, such as age-related macular degeneration, diabetic retinopathy, and macular edema. Common intravitreal injectables include anti-vascular endothelial growth factor (anti-VEGF) drugs, steroids, or other agents designed to address specific pathological processes within the eye. The injection is usually done in an outpatient setting, and the procedure helps to achieve a high concentration of the medication at the target site, minimizing systemic side effects. Intravitreal injectables have become a standard and effective approach in the management of retinal disorders, contributing to improved visual outcomes and preventing further progression of certain eye diseases.
According to DIResearch's in-depth investigation and research, the global Intravitreal Injectable market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Intravitreal Injectable include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Intravitreal Injectable. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Intravitreal Injectable market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Intravitreal Injectable market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Intravitreal Injectable industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Intravitreal Injectable Include:
Regeneron Pharmaceuticals (Eylea)
Allergan
EyePoint Pharmaceuticals
Genentech
Kanghong Pharmaceutical
Intravitreal Injectable Product Segment Include:
Anti-VEGF
Steroids
Others
Intravitreal Injectable Product Application Include:
Macular Degeneration
Macular Edema
Uveitis
Retinal Vein Occlusion
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Intravitreal Injectable Industry PESTEL Analysis
Chapter 3: Global Intravitreal Injectable Industry Porter’s Five Forces Analysis
Chapter 4: Global Intravitreal Injectable Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Intravitreal Injectable Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Intravitreal Injectable Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Intravitreal Injectable Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Intravitreal Injectable Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Intravitreal Injectable Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Intravitreal Injectable Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Intravitreal Injectable Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Intravitreal Injectable Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Intravitreal Injectable Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Intravitreal Injectable Product by Type
- 1.2.1 Anti-VEGF
- 1.2.2 Steroids
- 1.2.3 Others
- 1.3 Intravitreal Injectable Product by Application
- 1.3.1 Macular Degeneration
- 1.3.2 Macular Edema
- 1.3.3 Uveitis
- 1.3.4 Retinal Vein Occlusion
- 1.3.5 Others
- 1.4 Global Intravitreal Injectable Market Revenue and Sales Analysis
- 1.4.1 Global Intravitreal Injectable Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Intravitreal Injectable Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Intravitreal Injectable Market Sales Price Trend Analysis (2020-2032)
- 1.5 Intravitreal Injectable Industry Trends and Innovation
- 1.5.1 Intravitreal Injectable Industry Trends and Innovation
- 1.5.2 Intravitreal Injectable Market Drivers and Challenges
- 2 Intravitreal Injectable Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Intravitreal Injectable Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Intravitreal Injectable Market Analysis by Regions
- 4.1 Intravitreal Injectable Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Intravitreal Injectable Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Intravitreal Injectable Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Intravitreal Injectable Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Intravitreal Injectable Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Intravitreal Injectable Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Intravitreal Injectable Sales Forecast by Region (2026-2032)
- 4.4 Global Intravitreal Injectable Sales Price Trend Analysis (2020-2032)
- 5 Global Intravitreal Injectable Market Size by Type and Application
- 5.1 Global Intravitreal Injectable Market Size by Type
- 5.1.1 Global Intravitreal Injectable Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Intravitreal Injectable Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Intravitreal Injectable Market Size by Application
- 5.2.1 Global Intravitreal Injectable Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Intravitreal Injectable Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Intravitreal Injectable Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Intravitreal Injectable Market Size by Type
- 6.3.1 North America Intravitreal Injectable Sales by Type (2020-2032)
- 6.3.2 North America Intravitreal Injectable Revenue by Type (2020-2032)
- 6.4 North America Intravitreal Injectable Market Size by Application
- 6.4.1 North America Intravitreal Injectable Sales by Application (2020-2032)
- 6.4.2 North America Intravitreal Injectable Revenue by Application (2020-2032)
- 6.5 North America Intravitreal Injectable Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Intravitreal Injectable Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Intravitreal Injectable Market Size by Type
- 7.3.1 Europe Intravitreal Injectable Sales by Type (2020-2032)
- 7.3.2 Europe Intravitreal Injectable Revenue by Type (2020-2032)
- 7.4 Europe Intravitreal Injectable Market Size by Application
- 7.4.1 Europe Intravitreal Injectable Sales by Application (2020-2032)
- 7.4.2 Europe Intravitreal Injectable Revenue by Application (2020-2032)
- 7.5 Europe Intravitreal Injectable Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Intravitreal Injectable Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Intravitreal Injectable Market Size by Type
- 8.3.1 China Intravitreal Injectable Sales by Type (2020-2032)
- 8.3.2 China Intravitreal Injectable Revenue by Type (2020-2032)
- 8.4 China Intravitreal Injectable Market Size by Application
- 8.4.1 China Intravitreal Injectable Sales by Application (2020-2032)
- 8.4.2 China Intravitreal Injectable Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Intravitreal Injectable Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Intravitreal Injectable Market Size by Type
- 9.3.1 APAC (excl. China) Intravitreal Injectable Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Intravitreal Injectable Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Intravitreal Injectable Market Size by Application
- 9.4.1 APAC (excl. China) Intravitreal Injectable Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Intravitreal Injectable Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Intravitreal Injectable Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Intravitreal Injectable Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Intravitreal Injectable Market Size by Type
- 10.3.1 Latin America Intravitreal Injectable Sales by Type (2020-2032)
- 10.3.2 Latin America Intravitreal Injectable Revenue by Type (2020-2032)
- 10.4 Latin America Intravitreal Injectable Market Size by Application
- 10.4.1 Latin America Intravitreal Injectable Sales by Application (2020-2032)
- 10.4.2 Latin America Intravitreal Injectable Revenue by Application (2020-2032)
- 10.5 Latin America Intravitreal Injectable Market Size by Country
- 10.6 Latin America Intravitreal Injectable Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Intravitreal Injectable Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Intravitreal Injectable Market Size by Type
- 11.3.1 Middle East & Africa Intravitreal Injectable Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Intravitreal Injectable Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Intravitreal Injectable Market Size by Application
- 11.4.1 Middle East & Africa Intravitreal Injectable Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Intravitreal Injectable Revenue by Application (2020-2032)
- 11.5 Middle East Intravitreal Injectable Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Intravitreal Injectable Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Intravitreal Injectable Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Intravitreal Injectable Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Intravitreal Injectable Average Sales Price by Manufacturers (2021-2025)
- 12.2 Intravitreal Injectable Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Intravitreal Injectable Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Regeneron Pharmaceuticals (Eylea)
- 13.1.1 Regeneron Pharmaceuticals (Eylea) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product Portfolio
- 13.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 Allergan
- 13.2.1 Allergan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Allergan Intravitreal Injectable Product Portfolio
- 13.2.3 Allergan Intravitreal Injectable Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 EyePoint Pharmaceuticals
- 13.3.1 EyePoint Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 EyePoint Pharmaceuticals Intravitreal Injectable Product Portfolio
- 13.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 Genentech
- 13.4.1 Genentech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Genentech Intravitreal Injectable Product Portfolio
- 13.4.3 Genentech Intravitreal Injectable Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 Kanghong Pharmaceutical
- 13.5.1 Kanghong Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Kanghong Pharmaceutical Intravitreal Injectable Product Portfolio
- 13.5.3 Kanghong Pharmaceutical Intravitreal Injectable Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Intravitreal Injectable Industry Chain Analysis
- 14.2 Intravitreal Injectable Industry Raw Material and Suppliers Analysis
- 14.2.1 Intravitreal Injectable Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Intravitreal Injectable Typical Downstream Customers
- 14.4 Intravitreal Injectable Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
